SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000827871-14-000015
Filing Date
2014-12-22
Accepted
2014-12-22 15:29:21
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-K egrx_q4x2014.htm 10-K 1782630
2 EXHIBIT exhibit231.htm EX-23.1 2821
3 EXHIBIT exhibit311q4.htm EX-31.1 10996
4 EXHIBIT exhibit312q4.htm EX-31.2 10976
5 EXHIBIT exhibit321q4.htm EX-31.2 5761
12 ITEM 5 CHART egrx_q4x2014xchart-48806.jpg GRAPHIC 61152
  Complete submission text file 0000827871-14-000015.txt   8624616

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT egrx-20140930.xml EX-101.INS 1122165
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20140930.xsd EX-101.SCH 49285
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20140930_cal.xml EX-101.CAL 59928
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20140930_def.xml EX-101.DEF 245797
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20140930_lab.xml EX-101.LAB 624367
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20140930_pre.xml EX-101.PRE 358884
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-36306 | Film No.: 141302848
SIC: 2834 Pharmaceutical Preparations